Our study has also several limitations
At the time of this writing, liraglutide is the only GLP-1 RA with a labeled indication to reduce the risk of major adverse cardiovascular events (MACE), yet several other GLP-1 RAs have shown significant reduction in MACE, as summarized in Table 2
Before starting Obesema 0.5mg Injection (1 Multi-dose Disposable Pen, 4 Needles, 4 Alcohol Swabs), inform your doctor about any medical conditions you have, particularly a history of pancreatitis, eye problems caused by diabetes (diabetic retinopathy), thyroid cancer, or severe gastrointestinal problems
Charles EF, Lambert CG, Kerner B
"GLP-1 & Alcohol: What Happens When You Drink While on Treatment." January 2026
2012 May;103(4):257-9